| Tag | Content |
|---|
EnhancerAtlas ID | HS017-02225 |
Organism | Homo sapiens |
Tissue/cell | CD14+_monocyte |
Coordinate | chr1:160750830-160753160 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF8 | MA0652.1 | chr1:160752300-160752314 | ACTTTCAGTTTCGC | - | 6.59 |
|
| | Number of super-enhancer constituents: 8 | ID | Coordinate | Tissue/cell |
| SE_10180 | chr1:160750889-160752906 | CD19_Primary | | SE_11019 | chr1:160750029-160753160 | CD20 | | SE_18494 | chr1:160751364-160752309 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_20604 | chr1:160751157-160752587 | CD56 | | SE_32482 | chr1:160751449-160753061 | GM12878 | | SE_59420 | chr1:160736062-160761775 | Ly3 | | SE_61340 | chr1:160736320-160769570 | HBL1 | | SE_61981 | chr1:160736473-160771513 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I160780 | chr1 | 160750181 | 160753068 |
|
Enhancer Sequence | CACACTTTTC TCTCTGTACA GCTGCGTACA GAGAGAAAAG GCAGCATGGG GTCTAGGGTT 60
TGATTTCAAA TTGGAATCTG GAAGCACTGG CTACATAACT ACTTCTTAGA CTGGGTGATG 120
AGGGTCCTTG CCAAGCTGAA CTGAGGGGTC CTGTGACAAT AGCTGTGGTC ACGAGGAGTG 180
GGAGGGTGTT TGCTGTCTTG TGAGGGTGTG TGCACCAAGC CAGGGGACAT GCAGTGTCCT 240
GGTGCACTCA CCAGACTCCG CTGGCTGGCC CAATGTTATG TTCTTCCATG GAACTAACTA 300
TTCTGGCTCT GCCTGGAGTG GGCAGCAAGA AGCATCCCAC ACAGGGTGTT GCTGACACCA 360
GATAGATATT CCTCTCCCCA AATACAGCCC AGGCCTGAAA CCTAAGCTGG AGGTATTCCA 420
CCTGGAACAA GCAGCTTTGC CCCCGGCTTG TACCCTCTAG TGTGGTAACT CGCTAGACCG 480
GTTTCCATTC TGCTTCCTTG TTACAGCCTT ATCTGAGCTC TATACTTCTG GTCCAGCCAC 540
GCCTTCCCCT TAGTTTCCTT TGGCCTGTGC TTTTGTTGAA TTGTTTTGTT TCAAGCATTT 600
ACTTCATTCT GCCTCATACA AATAGCTGTG CTGTGTGTCT TTCCCTAGAG CCCATGAGCA 660
ACCCACGGAG AGAAGTTGGG AGGGAATTAA TATCTGAGTA ACAAGGTAAA GTAAGGCCAG 720
CGGTTTAGCC TCATAGTTAG GTGTAGTTGG GGGAATCCAG TGAATCCTGT TTCTGGATTC 780
AAGGGAGGAG GGGAAAGAGA CAGAGAAGGA TCAAATGCAG GGCACAAATC CCAAAAGCCA 840
GACACTTTGC CAAGCATATT ATGCACATTA CTTTCCTTAA CCTTCCCAAC AGACTTGTAA 900
GGTAGGTATT CTTTTATCTC CACTTTATAG ATGGAAGACC ATGAGACTCA AAGAGCTTAA 960
GGAACTTGCC CAAAGTCACC AGCTAGGAAC AGCAGAGTAC CGGTTAAAAC CCAGGTGTGT 1020
CTGTCCCCAG AATCAAGGCT CTGTTTACTA CACCAGCTGC CGGCAGCAGG CCTTCCCATG 1080
CCAAATTCTT TCCTGTGTCA CACTGTCACC CGCTTTTCCC TAGCCACACA CAGCATAGGA 1140
CCTGGCACAC AAGAGGACTT AACTGATGTT TCTAGAACTG AACTGAGGAA CTGTGAACAT 1200
TTTTAAGGCC ACACTTGTCT TACTCAATCT CTTGCCGTGG GCCCAAGAGA TGCCCCTGTG 1260
CTCAGTGATT ACCAAGGGCC TGGCCCAGAT GCTGTGGAGG GAGGAAAACA CCGATATGCA 1320
TGCTCCACAG TGGAAGAGGA AAAACGCAGG TGTGAGAAAC ATTGCAGTAA TCCAGCTTCT 1380
TGGTTTCAGT TCTGTCTTTG GTCAGGGACA CTGTGGTTCT CTGATACACT CCTTGTTGCT 1440
CCTACCCAAC AGCACAGTTG GGCTGTGCTG ACTTTCAGTT TCGCAGATCA CTGGAATATG 1500
CCACGTAATC TCTCTGAGCC TCAGTCTATC ATCTATAAAA TGGGTGAAAT GCTACCTGCC 1560
TTGTCCATAT CACAAGACTG TTATAGGGAT CACTTTTTTT TTTTTCGAGA TGGAATTTTG 1620
CTCTTGTTGC CCAGGCTGGA GTGCAATGGC ACGATCTCAG CTCACTGCAA CCTCCGCCTC 1680
CTGGGTTCAA GCAATTCTTC TGCCTTAGCC TCCTGAGTAG TTGGGATTAC AGGCATCCAC 1740
CACCATGCCC GGCTAATTTT GTATTTTTTA GTAGAGATGA GGTTTCTCCA TGTTGATCAG 1800
GCTGGTCTCA AACTCCCAAC CTCAGGTGAT CCACCTGCCT CAGCCTCCCA AAGTTCTGGG 1860
ATTACATGTG TGAGCCAGTG CACCTGGCCA GGGATCACGT TTTTAAAGAT TTAAGTTAAA 1920
GTTCTTGATG AACTATCAAG GTTTAAACAC ATCTAGGGGA TTCATCAGTT TATTAAAGGA 1980
GATCCCTAAA GGCTGGGGTG AAAACAACCC TGAACGCAGG TGACTCTAAG AACAGAATGT 2040
GGGGGAGGAG CCAAGATGGC CGAATAGGAA CAGCTCCGGT CTACAGCTCC CAGCATGAGC 2100
GACGCAGAAG ATGGGTGATT TCTGCATTTC CGTCTGAGGT ACCAGGTTCA TCACACTAGG 2160
GAGTGCCAGA CAGTGGGCAC AGGTCAGTGG GTGCAGCACA CCGTGCACGA GCCAAAGCAG 2220
GGCGAGGCAT TGCCTCGCTC GGGAAGCGCA CAGGGTCAGG GAGTTCCCTT TCCTAGTCAA 2280
AGAAAGGGGT GACAGACGGC ACCTGGAAAA TCGGGTCACT CCCACCCGAA 2330
|
